VR Discovery Nanome operates at the intersection of VR and molecular science, offering an immersive platform for 3D molecule manipulation and collaboration. This presents a sales opportunity to target research labs, pharmaceutical companies, and academic institutions seeking cutting-edge visualization tools to accelerate drug design and structural biology workflows.

AI Copilot MARA The launch of MARA, an AI copilot for generative assistance in molecular science, signals a pathway to upsell advanced automation and AI-assisted design features. Target customers with large-scale or repetitive modeling tasks who could benefit from AI-assisted workflows and faster hypothesis testing.

CryoEM Plug-in The CyroEM plug-in expands Nanome’s applicability to cryo-electron microscopy workflows, enabling researchers to view and manipulate cryo-EM data within the XR environment. This creates a cross-sell opportunity to labs and consortia focused on structural biology and high-resolution imaging.

Global Partnerships Recent partnerships with Fujitsu and other strategic collaborations indicate a market push into enterprise and international markets. Use this momentum to propose enterprise licenses, regional deployments, and integrations with enterprise IT ecosystems for large research centers and universities abroad.

Funding & Growth With reported revenue in the multi-million range and a total funding of fourteen million dollars, Nanome shows growth potential and market validation. This supports outreach to mid-size to large labs that seek scalable, well-funded software platforms and potential co-development or sponsorship opportunities.